{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T17:34:43Z","timestamp":1793295283246,"version":"4.5.0"},"reference-count":149,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T00:00:00Z","timestamp":1753315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T00:00:00Z","timestamp":1753315200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Prader-Willi syndrome (PWS) is a rare, genetic neurobehavioral and metabolic disorder marked by hyperphagia, behavioral challenges, and significant comorbidities, requiring a multidisciplinary approach for effective management. This systematic review aimed to comprehensively evaluate the burden of disease associated with PWS, focusing on mortality, healthcare resource utilization, economic burden, and quality of life.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>The literature search, conducted on August 13, 2024, included the MEDLINE, Embase, and Cochrane Library databases, as well as conference proceedings. Original studies published since 2014 were selected based on relevance to PWS patient burden, covering mortality, humanistic and economic impacts. Data from the selected studies were extracted, and currency conversions were standardized.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>For the topics of mortality, humanistic burden and economic burden, a total of 11 studies, 95 studies, and 33 studies were included, respectively. Individuals with PWS faced significantly reduced life expectancy compared to the general population, with leading causes of death including respiratory failure, consequences of uncontrolled hyperphagia, and cardiovascular complications. Hyperphagia contributed substantially to the disease burden, necessitating constant food security measures to prevent life-threatening complications. Primary caregivers, predominantly parents of individuals with PWS, experienced significant emotional and psychological strain. The time-intensive responsibilities of implementing food security measures heavily impacted their daily lives, social and family dynamics, as well as their financial health. Quality of life for patients was less frequently reported but markedly impaired, driven by physical health challenges, behavioral issues, and social isolation. Wider family dynamics were also often impacted, with siblings reporting increased psychosocial stress and feelings of neglect. The direct costs of managing PWS, including frequent hospitalizations and specialized care, were consistently reported to exceed those of matched controls without PWS, highlighting the substantial economic burden associated with the condition.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>This systematic literature review highlights the profound burden of PWS on patients, caregivers, payers of care, and healthcare systems. Complications of PWS reduce life expectancy, impair quality of life, and impose considerable financial strain. The findings underscore an urgent need for comprehensive support and innovative treatments that address the complex manifestations and consequences of PWS, particularly hyperphagia, to improve outcomes for patients and their families.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s13023-025-03787-0","type":"journal-article","created":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T14:24:09Z","timestamp":1753367049000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["The burden of illness in Prader-Willi syndrome: a systematic literature review"],"prefix":"10.1186","volume":"20","author":[{"given":"Dairine","family":"Dempsey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Hall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben","family":"Lanning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben","family":"Barron-Millar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil","family":"Cowen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitch","family":"Nagao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raj","family":"Gandhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anish","family":"Bhatnagar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,24]]},"reference":[{"issue":"12","key":"3787_CR1","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1007\/s40618-015-0312-9","volume":"38","author":"MA Angulo","year":"2015","unstructured":"Angulo MA, Butler MG, Cataletto ME. Prader-Willi syndrome: a review of clinical, genetic, and endocrine findings. J Endocrinol Invest. 2015;38(12):1249\u201363.","journal-title":"J Endocrinol Invest"},{"issue":"1","key":"3787_CR2","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1038\/gim.0b013e31822bead0","volume":"14","author":"SB Cassidy","year":"2012","unstructured":"Cassidy SB, Schwartz S, Miller JL, Driscoll DJ. Prader-Willi syndrome. Genet Med. 2012;14(1):10\u201326.","journal-title":"Genet Med"},{"key":"3787_CR3","unstructured":"Driscoll DJ, Miller J. L., Cassidy S. B. Prader-Willi Syndrome. Adam M. P. FJ, Mirzaa G. M., Pagon R. A., Wallace S. E., Bean L. J. H., et al, editor. GeneReviews2023."},{"issue":"3","key":"3787_CR4","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1111\/cge.13142","volume":"93","author":"AM Manzardo","year":"2018","unstructured":"Manzardo AM, Weisensel N, Ayala S, Hossain W, Butler MG. Prader-Willi syndrome genetic subtypes and clinical neuropsychiatric diagnoses in residential care adults. Clin Genet. 2018;93(3):622\u201331.","journal-title":"Clin Genet"},{"issue":"9","key":"3787_CR5","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3390\/genes10090713","volume":"10","author":"J Bohonowych","year":"2019","unstructured":"Bohonowych J, Miller J, McCandless SE, Strong TV. The global Prader-Willi syndrome registry: development, launch, and early demographics. Genes (Basel). 2019;10(9):14.","journal-title":"Genes (Basel)"},{"key":"3787_CR6","unstructured":"Disorders NOfR. Prader-Willi Syndrome. 2023."},{"key":"3787_CR7","first-page":"113","volume":"11","author":"JL Miller","year":"2020","unstructured":"Miller JL, Tan M. Dietary Management for Adolescents with Prader-Willi Syndrome. Adolesc Health Med Ther. 2020;11:113\u20138.","journal-title":"Adolesc Health Med Ther"},{"issue":"1","key":"3787_CR8","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s11689-021-09373-2","volume":"13","author":"L Schwartz","year":"2021","unstructured":"Schwartz L, Caix\u00e0s A, Dimitropoulos A, Dykens E, Duis J, Einfeld S, Gallagher L, Holland A, Rice L, Roof E, Salehi P, Strong T, Taylor B, Woodcock K. Behavioral features in Prader-Willi syndrome (PWS): consensus paper from the International PWS Clinical Trial Consortium. J Neurodev Disord. 2021;13(1):25.","journal-title":"J Neurodev Disord"},{"issue":"10","key":"3787_CR9","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1038\/ijo.2017.139","volume":"41","author":"E Hedgeman","year":"2017","unstructured":"Hedgeman E, Ulrichsen SP, Carter S, Kreher NC, Malobisky KP, Braun MM, et al. Long-term health outcomes in patients with Prader-Willi Syndrome: a nationwide cohort study in Denmark. Int J Obes (Lond). 2017;41(10):1531\u20138.","journal-title":"Int J Obes (Lond)"},{"issue":"1","key":"3787_CR10","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1210\/clinem\/dgac556","volume":"108","author":"DH van Abswoude","year":"2022","unstructured":"van Abswoude DH, Pellikaan K, Rosenberg AGW, Davidse K, Coupaye M, Hoybye C, et al. Bone health in adults with Prader-Willi syndrome: clinical recommendations based on a multicenter cohort study. J Clin Endocrinol Metab. 2022;108(1):59\u201384.","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"3787_CR11","doi-asserted-by":"publisher","first-page":"2057","DOI":"10.1007\/s40618-021-01574-9","volume":"44","author":"G Muscogiuri","year":"2021","unstructured":"Muscogiuri G, Barrea L, Faggiano F, Maiorino MI, Parrillo M, Pugliese G, et al. Obesity in Prader-Willi syndrome: physiopathological mechanisms, nutritional and pharmacological approaches. J Endocrinol Invest. 2021;44(10):2057\u201370.","journal-title":"J Endocrinol Invest"},{"issue":"2","key":"3787_CR12","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1111\/jar.12669","volume":"33","author":"A Bellicha","year":"2020","unstructured":"Bellicha A, Coupaye M, Hocquaux L, Speter F, Oppert J, Poitou CM. Increasing physical activity in adult women with Prader-Willi syndrome: a transferability study. J Appl Res Intellect Disabil. 2020;33(2):258\u201367.","journal-title":"J Appl Res Intellect Disabil."},{"issue":"3","key":"3787_CR13","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1016\/j.neubiorev.2010.10.015","volume":"35","author":"L Reus","year":"2011","unstructured":"Reus L, Zwarts M, van Vlimmeren LA, Willemsen MA, Otten BJ, Sanden MW. Motor problems in Prader-Willi syndrome: a systematic review on body composition and neuromuscular functioning. Neurosci Biobehav Rev. 2011;35(3):956\u201369.","journal-title":"Neurosci Biobehav Rev."},{"issue":"5","key":"3787_CR14","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1111\/cen.13953","volume":"90","author":"JS Morales","year":"2019","unstructured":"Morales JS, Valenzuela PL, Pareja-Galeano H, Rincon-Castanedo C, Rubin DA, Lucia A. Physical exercise and Prader-Willi syndrome: a systematic review. Clin Endocrinol (Oxf). 2019;90(5):649\u201361.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"3","key":"3787_CR15","doi-asserted-by":"publisher","first-page":"e0248739","DOI":"10.1371\/journal.pone.0248739","volume":"16","author":"N Kayadjanian","year":"2021","unstructured":"Kayadjanian N, Vrana-Diaz C, Bohonowych J, Strong TV, Morin J, Potvin D, Schwartz L. Characteristics and relationship between hyperphagia, anxiety, behavioral challenges and caregiver burden in Prader-Willi syndrome. PLoS ONE. 2021;16(3):e0248739.","journal-title":"PLoS ONE"},{"issue":"5","key":"3787_CR16","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1111\/apa.15738","volume":"110","author":"C Meade","year":"2021","unstructured":"Meade C, Martin R, McCrann A, Lyons J, Meehan J, Hoey H, Roche E. Prader-Willi syndrome in children: quality of life and caregiver burden. Acta Paediatr. 2021;110(5):1665\u201370.","journal-title":"Acta Paediatr"},{"issue":"5","key":"3787_CR17","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1530\/EC-18-0089","volume":"7","author":"AC Paepegaey","year":"2018","unstructured":"Paepegaey AC, Coupaye M, Jaziri A, Menesguen F, Dubern B, Polak M, Oppert JM, Tauber M, Pinto G, Poitou C. Impact of transitional care on endocrine and anthropometric parameters in Prader-Willi syndrome. Endocr Connect. 2018;7(5):663\u201372.","journal-title":"Endocr Connect"},{"issue":"10","key":"3787_CR18","doi-asserted-by":"publisher","first-page":"2899","DOI":"10.1002\/ajmg.a.62901","volume":"188","author":"J Luccarelli","year":"2022","unstructured":"Luccarelli J. Demographics and medical comorbidities among hospitalized patients with Prader-Willi Syndrome: a national inpatient sample analysis. Am J Med Genet A. 2022;188(10):2899\u2013907.","journal-title":"Am J Med Genet A"},{"issue":"1","key":"3787_CR19","doi-asserted-by":"publisher","first-page":"S288","DOI":"10.1016\/j.ajog.2017.11.006","volume":"218","author":"CM Avram","year":"2018","unstructured":"Avram CM, Allen AJ, Shaffer BL, Caughey AB. The impact of Prader Willi Syndrome on perinatal outcomes. Am J Obst Gynecol. 2018;218(1):S288\u20139.","journal-title":"Am J Obst Gynecol."},{"issue":"1","key":"3787_CR20","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1136\/bmjopen-2017-019113","volume":"8","author":"J Bourke","year":"2018","unstructured":"Bourke J, Wong K, Leonard H. Validation of intellectual disability coding through hospital morbidity records using an intellectual disability population-based database in Western Australia. BMJ Open. 2018;8(1):963.","journal-title":"BMJ Open."},{"issue":"2","key":"3787_CR21","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1002\/ajmg.a.38582","volume":"176","author":"MG Butler","year":"2018","unstructured":"Butler MG, Kimonis V, Dykens E, Gold JA, Miller J, Tamura R, et al. Prader-Willi syndrome and early-onset morbid obesity NIH rare disease consortium: a review of natural history study. Am J Med Genet A. 2018;176(2):368\u201375.","journal-title":"Am J Med Genet A"},{"issue":"6","key":"3787_CR22","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1038\/gim.2016.178","volume":"19","author":"MG Butler","year":"2017","unstructured":"Butler MG, Manzardo AM, Heinemann J, Loker C, Loker J. Causes of death in Prader-Willi syndrome: Prader-Willi syndrome association (USA) 40-year mortality survey. Genet Med. 2017;19(6):635\u201342.","journal-title":"Genet Med"},{"issue":"1","key":"3787_CR23","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/gim.2017.92","volume":"20","author":"AM Manzardo","year":"2018","unstructured":"Manzardo AM, Loker J, Heinemann J, Loker C, Butler MG. Survival trends from the Prader-Willi Syndrome Association (USA) 40-year mortality survey. Genet Med. 2018;20(1):24\u201330.","journal-title":"Genet Med"},{"key":"3787_CR24","doi-asserted-by":"publisher","first-page":"A504","DOI":"10.1210\/jendso\/bvaa046.993","volume":"4","author":"SE McCandless","year":"2020","unstructured":"McCandless SE, Suh M, Yin D, Yeh M, Czado S, Aghsaei S, et al. U.S. prevalence & mortality of Prader-Willi syndrome: a population-based study of medical claims. J Endocr Soc. 2020;4:A504\u20135.","journal-title":"J Endocr Soc"},{"issue":"1","key":"3787_CR25","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1186\/s13023-019-1214-2","volume":"14","author":"DL Pacoricona Alfaro","year":"2019","unstructured":"Pacoricona Alfaro DL, Lemoine P, Ehlinger V, Molinas C, Diene G, Valette M, et al. Causes of death in Prader-Willi syndrome: lessons from 11 years\u2019 experience of a national reference center. Orphanet J Rare Dis. 2019;14(1):238.","journal-title":"Orphanet J Rare Dis"},{"issue":"Supplement 2","key":"3787_CR26","first-page":"1520","volume":"27","author":"JN Proffit","year":"2019","unstructured":"Proffit JN, Osann K, MacManus B, Butler MG, Kimonis VE, Heinemann J, Stevenson D, Gold JA. A lower BMI and growth hormone use results in decreased mortality in Prader-Willi syndrome. Eur J Hum Genet. 2019;27(Supplement 2):1520\u20131.","journal-title":"Eur J Hum Genet"},{"issue":"2","key":"3787_CR27","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1002\/ajmg.a.60688","volume":"179","author":"J Proffitt","year":"2019","unstructured":"Proffitt J, Osann K, McManus B, Kimonis VE, Heinemann J, Butler MG, et al. Contributing factors of mortality in Prader-Willi syndrome. Am J Med Genet A. 2019;179(2):196\u2013205.","journal-title":"Am J Med Genet A"},{"issue":"3","key":"3787_CR28","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1017\/S0033291714001755","volume":"45","author":"JE Whittington","year":"2015","unstructured":"Whittington JE, Holland AJ, Webb T. Ageing in people with Prader-Willi syndrome: mortality in the UK population cohort and morbidity in an older sample of adults. Psychol Med. 2015;45(3):615\u201321.","journal-title":"Psychol Med"},{"issue":"1","key":"3787_CR29","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1186\/s13023-018-0924-1","volume":"13","author":"D Adams","year":"2018","unstructured":"Adams D, Hastings RP, Alston-Knox C, Cianfaglione R, Eden K, Felce D, Griffith G, Moss J, Stinton C, Oliver C. Using Bayesian methodology to explore the profile of mental health and well-being in 646 mothers of children with 13 rare genetic syndromes in relation to mothers of children with autism. Orphanet J Rare Dis. 2018;13(1):185.","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"3787_CR30","doi-asserted-by":"publisher","first-page":"e0190849","DOI":"10.1371\/journal.pone.0190849","volume":"13","author":"S Allas","year":"2018","unstructured":"Allas S, Caix\u00e0s A, Poitou C, Coupaye M, Thuilleaux D, Lorenzini F, Diene G, Crin\u00f2 A, Illouz F, Grugni G, et al. AZP-531, an unacylated ghrelin analog, improves food-related behavior in patients with Prader-Willi syndrome: a randomized placebo-controlled trial. PLoS ONE. 2018;13(1):e0190849.","journal-title":"PLoS ONE"},{"key":"3787_CR31","first-page":"746311","volume":"10","author":"AS Amaro","year":"2022","unstructured":"Amaro AS, Rubin DA, Teixeira MFAJ, Rodrigues GM, Carreiro LRR. Health problems in individuals with PWS are associated with lower quality of life for their parents: a snapshot in the brazilian population. Front. 2022;10:746311.","journal-title":"Front."},{"issue":"3","key":"3787_CR32","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1352\/1944-7558-129.3.175","volume":"129","author":"SM Andrews","year":"2024","unstructured":"Andrews SM, Panjwani AA, Potter SN, Hamrick LR, Wheeler AC, Kelleher BL. Specificity of early childhood hyperphagia profiles in neurogenetic conditions. Am J Intellect Dev Disabil. 2024;129(3):175\u201390.","journal-title":"Am J Intellect Dev Disabil"},{"key":"3787_CR33","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.comppsych.2014.12.005","volume":"58","author":"H Avrahamy","year":"2015","unstructured":"Avrahamy H, Pollak Y, Shriki-Tal L, Genstil L, Hirsch HJ, Gross-Tsur V, Benarroch F. A disease specific questionnaire for assessing behavior in individuals with Prader-Willi syndrome. Compr Psychiatry. 2015;58:189\u201397.","journal-title":"Compr Psychiatry"},{"key":"3787_CR34","first-page":"26","volume":"26","author":"C Baietto","year":"2023","unstructured":"Baietto C, Bechis D, Caldarera AM, Marcotulli D, Natali SM. Children with Prader-Willi Syndrome and COVID-19: a longitudinal study of the effect of social re-opening after the lockdown. Minerva Pediatr (Torino). 2023;26:26.","journal-title":"Minerva Pediatr (Torino)"},{"issue":"4","key":"3787_CR35","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1159\/000437141","volume":"84","author":"NE Bakker","year":"2015","unstructured":"Bakker NE, Siemensma EP, van Rijn M, Festen DA, Hokken-Koelega AC. Beneficial effect of growth hormone treatment on health-related quality of life in children with Prader-Willi syndrome: a randomized controlled trial and longitudinal study. Hormone Res Paediat. 2015;84(4):231\u20139.","journal-title":"Hormone Res Paediat"},{"key":"3787_CR36","doi-asserted-by":"publisher","first-page":"897138","DOI":"10.3389\/fpsyt.2022.897138","volume":"13","author":"A Bos-Roubos","year":"2022","unstructured":"Bos-Roubos A, Wingbermuhle E, Biert A, de Graaff L, Egger J. Family matters: trauma and quality of life in family members of individuals with Prader-Willi syndrome. Front Psychiatr. 2022;13:897138.","journal-title":"Front Psychiatr"},{"issue":"2","key":"3787_CR37","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1002\/ajmg.b.32401","volume":"171B","author":"GL Bravo","year":"2016","unstructured":"Bravo GL, Poje AB, Perissinotti I, Marcondes BF, Villamar MF, Manzardo AM, Luque L, LePage JF, Stafford D, Fregni F, Butler MG. Transcranial direct current stimulation reduces food-craving and measures of hyperphagia behavior in participants with Prader-Willi syndrome. Am J Med Genet B Neuropsychiatr Genet. 2016;171B(2):266\u201375.","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"issue":"Supplement 1","key":"3787_CR38","doi-asserted-by":"publisher","first-page":"S256","DOI":"10.1016\/j.jval.2018.04.1779","volume":"21","author":"JF Bridges","year":"2018","unstructured":"Bridges JF, Lavelle T, Tsai J, Kayadjanian N, Strong T. Assessing the potential impact of treating hyperphagia among people with prader-willi syndrome using disease-specific qalys. Value in Health. 2018;21(Supplement 1):S256.","journal-title":"Value in Health"},{"key":"3787_CR39","doi-asserted-by":"crossref","unstructured":"Butler MG, McCandless S, Roof E, Dykens EM, Fu C, Stafford DEJ, et al. Weight loss and improvement in hyperphagia-related behavior: results from bestpws, a phase 3, randomized, placebo-controlled, clinical trial of beloranib, a methionine aminopeptidase 2 (MetAP2) inhibitor, in patients with prader-willi syndrome. Endocrine Reviews Conference: 98th Annual Meeting and Expo of the Endocrine Society, ENDO. 2016;37(2 Supplement 1).","DOI":"10.1093\/edrv\/37.supp.1"},{"issue":"1","key":"3787_CR40","doi-asserted-by":"publisher","first-page":"228","DOI":"10.16993\/sjdr.13","volume":"20","author":"D Cagalj","year":"2018","unstructured":"Cagalj D, Buljevac M, Leutar Z. Being a mother of a child with Prader-Willi syndrome: experiences of accessing and using formal support in Croatia. Scand J Disabil Res. 2018;20(1):228\u201337.","journal-title":"Scand J Disabil Res"},{"issue":"9","key":"3787_CR41","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1111\/jir.12288","volume":"60","author":"K Chevreul","year":"2016","unstructured":"Chevreul K, Berg BK, Clement MC, Poitou C, Tauber M. Economic burden and health-related quality of life associated with Prader-Willi syndrome in France. J Intellect Disabil Res. 2016;60(9):879\u201390.","journal-title":"J Intellect Disabil Res"},{"issue":"2","key":"3787_CR42","first-page":"122","volume":"59","author":"F Chiarotti","year":"2023","unstructured":"Chiarotti F, Kodra Y, De Santis M, Bellenghi M, Taruscio D, Care A, Petrini M. Gender and burden differences in family caregivers of patients affected by ten rare diseases. Ann Ist Super Sanita. 2023;59(2):122\u201331.","journal-title":"Ann Ist Super Sanita"},{"key":"3787_CR43","doi-asserted-by":"publisher","first-page":"e4097","DOI":"10.7717\/peerj.4097","volume":"5","author":"VJ Chiu","year":"2017","unstructured":"Chiu VJ, Tsai LP, Wei JT, Tzeng IS, Wu HC. Motor performance in Prader-Willi syndrome patients and its potential influence on caregiver\u2019s quality of life. PeerJ. 2017;5:e4097.","journal-title":"PeerJ"},{"issue":"6","key":"3787_CR44","doi-asserted-by":"publisher","first-page":"2491","DOI":"10.1007\/s00431-022-04439-2","volume":"181","author":"CS Choong","year":"2022","unstructured":"Choong CS, Nixon GM, Blackmore AM, Chen W, Jacoby P, Leonard H, Lafferty AR, Ambler G, Kapur N, Bergman PB, Schofield C, Seton C, Tai A, Tham E, Vora K, Crock P, Verge C, Musthaffa Y, Blecher G, Wilson A, Downs J. Daytime sleepiness and emotional and behavioral disturbances in Prader-Willi syndrome. Eur J Pediatr. 2022;181(6):2491\u2013500.","journal-title":"Eur J Pediatr"},{"issue":"2","key":"3787_CR45","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.jval.2022.08.004","volume":"26","author":"SP Cotter","year":"2023","unstructured":"Cotter SP, Schwartz L, Strong TV, Bender RH, Fehnel SE. The Prader-Willi syndrome anxiousness and distress behaviors questionnaire: development and psychometric validation. Value in Health. 2023;26(2):243\u201350.","journal-title":"Value in Health"},{"issue":"12","key":"3787_CR46","doi-asserted-by":"publisher","first-page":"4895","DOI":"10.1210\/jc.2016-2163","volume":"101","author":"M Coupaye","year":"2016","unstructured":"Coupaye M, Tauber M, Cuisset L, Laurier V, Bieth E, Lacorte JM, Oppert JM, Clement K, Poitou C. Effect of genotype and previous GH treatment on adiposity in adults with Prader-Willi syndrome. J Clin Endocrinol Metab. 2016;101(12):4895\u2013903.","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"3787_CR47","first-page":"52","volume":"12","author":"R Coutant","year":"2023","unstructured":"Coutant R, Tauber M, Demaret B, Henocque R, Brault Y, Montestruc F, Chassany O, Polak M. Treatment burden, adherence, and quality of life in children with daily GH treatment in France. End Connect. 2023;12(4):52.","journal-title":"End Connect."},{"key":"3787_CR48","first-page":"5104","volume":"52","author":"G Currie","year":"2024","unstructured":"Currie G, Estefan A, Caine V. Mothering a child with complexity and rarity: a narrative inquiry exploring Prader-Willi syndrome. Qual Health Res. 2024;52:5104.","journal-title":"Qual Health Res."},{"issue":"Supplement 1","key":"3787_CR49","first-page":"865","volume":"26","author":"A Dobrescu","year":"2019","unstructured":"Dobrescu A, Chirita-Emandi A, Andreescu N, Farcas S, Puiu M. Hyperphagia questionnaire to evaluate the Prader Willi patients behavior related to food. Eur J Hum Genet. 2019;26(Supplement 1):865\u20136.","journal-title":"Eur J Hum Genet"},{"issue":"5","key":"3787_CR50","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1002\/ajmg.a.62671","volume":"188","author":"J Downs","year":"2022","unstructured":"Downs J, Blackmore AM, Chen W, Nixon GM, Choong CS. Strengths and challenging behaviors in children and adolescents with Prader-Willi syndrome: two sides to the coin. Am J Med Genet A. 2022;188(5):1488\u201396.","journal-title":"Am J Med Genet A"},{"issue":"1","key":"3787_CR51","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s13023-024-03045-9","volume":"19","author":"EM Dykens","year":"2024","unstructured":"Dykens EM, Roof E, Hunt-Hawkins H. The Prader-Willi syndrome Profile: validation of a new measure of behavioral and emotional problems in Prader-Willi syndrome. Orphanet J Rare Dis. 2024;19(1):83.","journal-title":"Orphanet J Rare Dis"},{"key":"3787_CR52","first-page":"56","volume":"28","author":"EM Dykens","year":"2024","unstructured":"Dykens EM, Roof E, Hunt-Hawkins H. Validation of the food safe zone questionnaire for families of individuals with Prader-Willi syndrome. medRxiv. 2024;28:56.","journal-title":"medRxiv."},{"issue":"9","key":"3787_CR53","doi-asserted-by":"publisher","first-page":"2232","DOI":"10.1002\/ajmg.a.36653","volume":"164","author":"SL Einfeld","year":"2014","unstructured":"Einfeld SL, Smith E, McGregor IS, Steinbeck K, Taffe J, Rice LJ, Horstead SK, Rogers N, Hodge MA, Guastella AJ. A double-blind randomized controlled trial of oxytocin nasal spray in Prader Willi syndrome. Am J Med Genet A. 2014;164(9):2232\u20139.","journal-title":"Am J Med Genet A"},{"key":"3787_CR54","unstructured":"EUCTR. A Clinical Study in patients with Prader-Willi-Syndrome (PWS) to test if a study drug named livoletide can reduce food related behaviour and be safe and well tolerated [Trial registry record]. 2019 [Available from: https:\/\/trialsearch.who.int\/Trial2.aspx?TrialID=EUCTR2018-003062-13-ES]. Last accessed Last accessed: 31 January 2025."},{"key":"3787_CR55","unstructured":"Faye S, Molinas, C., Brochado, C., Valette, M., Desprez, C., Diene, G., Arnaud, C., Tauber, M. The evolution of diagnosis and care over time in children with Prader-Willi syndrome, born between 2005 and 2021, included in the French database. European Societ for Paediatric Endocrinology meeting 2023. 2023."},{"issue":"2","key":"3787_CR56","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1111\/jir.12707","volume":"64","author":"SM Feighan","year":"2020","unstructured":"Feighan SM, Hughes M, Maunder K, Roche E, Gallagher L. A profile of mental health and behaviour in Prader-Willi syndrome. J Intellect Disabil Res. 2020;64(2):158\u201369.","journal-title":"J Intellect Disabil Res"},{"issue":"9","key":"3787_CR57","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1111\/jir.12259","volume":"60","author":"T Foerste","year":"2016","unstructured":"Foerste T, Sabin M, Reid S, Reddihough D. Understanding the causes of obesity in children with trisomy 21: hyperphagia vs physical inactivity. J Intellect Disabil Res. 2016;60(9):856\u201364.","journal-title":"J Intellect Disabil Res"},{"issue":"3","key":"3787_CR58","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.dhjo.2017.12.003","volume":"11","author":"C Friedman","year":"2018","unstructured":"Friedman C. The personal outcome measures. Disabil Health J. 2018;11(3):351\u20138.","journal-title":"Disabil Health J"},{"issue":"2","key":"3787_CR59","doi-asserted-by":"publisher","first-page":"8","DOI":"10.4081\/pmc.2015.107","volume":"37","author":"L Giordano","year":"2015","unstructured":"Giordano L, Toma S, Palonta F, Teggi R, Zucconi M, Di Candia S, Bussi M. Obstructive sleep apnea in Prader-Willi syndrome: risks and advantages of adenotonsillectomy. Pediatr Med Chir. 2015;37(2):8\u201311.","journal-title":"Pediatr Med Chir"},{"issue":"1","key":"3787_CR60","doi-asserted-by":"publisher","first-page":"e13162","DOI":"10.1111\/cch.13162","volume":"50","author":"Y Gonzalez Ruiz","year":"2024","unstructured":"Gonzalez Ruiz Y, Gerk A, Stegmann J. Mental health impact on primary and secondary Prader-Willi syndrome caregivers. Child Care Health Dev. 2024;50(1):e13162.","journal-title":"Child Care Health Dev"},{"issue":"8","key":"3787_CR61","first-page":"635","volume":"11","author":"S Grolleau","year":"2022","unstructured":"Grolleau S, Delagrange M, Souquiere M, Molinas C, Diene G, Valette M, Tauber M. Impact of deprivation on obesity in children with PWS. Journal. 2022;11(8):635.","journal-title":"Journal"},{"issue":"Supplement 1","key":"3787_CR62","first-page":"A510","volume":"4","author":"R Harisseh","year":"2020","unstructured":"Harisseh R, Delale T, Yeh M, Allas S. Livoletide (AZP-531), an unacylated ghrelin analogue, improves hyperphagia and food-related behaviors both in obese and non-obese people with Prader-Willi syndrome. J Endocrine Soc. 2020;4(Supplement 1):A510\u20131.","journal-title":"J Endocrine Soc"},{"key":"3787_CR63","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/j.jpsychires.2020.11.006","volume":"137","author":"E Hollander","year":"2021","unstructured":"Hollander E, Levine KG, Ferretti CJ, Freeman K, Doernberg E, Desilva N, Taylor BP. Intranasal oxytocin versus placebo for hyperphagia and repetitive behaviors in children with Prader-Willi syndrome: a randomized controlled pilot trial. J Psychiatr Res. 2021;137:643\u201351.","journal-title":"J Psychiatr Res"},{"key":"3787_CR64","doi-asserted-by":"publisher","first-page":"100084","DOI":"10.1016\/j.obpill.2023.100084","volume":"8","author":"KE Honea","year":"2023","unstructured":"Honea KE, Wilson KS, Fisher KL, Rubin DA. Parental and familial factors related to participation in a home-based physical activity intervention in children with obesity or Prader-Willi syndrome. Obes Pillars. 2023;8:100084.","journal-title":"Obes Pillars"},{"issue":"9","key":"3787_CR65","doi-asserted-by":"publisher","first-page":"2226","DOI":"10.1002\/ajmg.a.36634","volume":"164","author":"H Ihara","year":"2014","unstructured":"Ihara H, Ogata H, Sayama M, Kato A, Gito M, Murakami N, Kido Y, Nagai T. QOL in caregivers of Japanese patients with Prader-Willi syndrome with reference to age and genotype. Am J Med Genet A. 2014;164(9):2226\u201331.","journal-title":"Am J Med Genet A"},{"issue":"3","key":"3787_CR66","doi-asserted-by":"publisher","first-page":"e0194655","DOI":"10.1371\/journal.pone.0194655","volume":"13","author":"N Kayadjanian","year":"2018","unstructured":"Kayadjanian N, Schwartz L, Farrar E, Comtois KA, Strong TV. High levels of caregiver burden in Prader-Willi syndrome. PLoS ONE. 2018;13(3):e0194655.","journal-title":"PLoS ONE"},{"issue":"8","key":"3787_CR67","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1001\/jamapsychiatry.2019.0566","volume":"76","author":"KM Kendall","year":"2019","unstructured":"Kendall KM, Rees E, Bracher-Smith M, Legge S, Riglin L, Zammit S, O\u2019Donovan MC, Owen MJ, Jones I, Kirov G, Walters JTR. Association of rare copy number variants with risk of depression. JAMA Psychiat. 2019;76(8):818\u201325.","journal-title":"JAMA Psychiat"},{"issue":"9","key":"3787_CR68","doi-asserted-by":"publisher","first-page":"e0273295","DOI":"10.1371\/journal.pone.0273295","volume":"17","author":"K Kowal","year":"2022","unstructured":"Kowal K, Skrzypek M, Kocki J. Experiencing illness as a crisis by the caregivers of individuals with Prader-Willi syndrome. PLoS ONE. 2022;17(9):e0273295.","journal-title":"PLoS ONE"},{"issue":"6","key":"3787_CR69","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1007\/s00787-020-01568-7","volume":"30","author":"M Krefft","year":"2021","unstructured":"Krefft M, Frydecka D, Zalsman G, Krzystek-Korpacka M, Smigiel R, Gebura K, Bogunia-Kubik K, Misiak B. A pro-inflammatory phenotype is associated with behavioural traits in children with Prader-Willi syndrome. Eur Child Adolesc Psychiatry. 2021;30(6):899\u2013908.","journal-title":"Eur Child Adolesc Psychiatry"},{"issue":"1","key":"3787_CR70","first-page":"140","volume":"13","author":"TA Lavelle","year":"2020","unstructured":"Lavelle TA, Crossnohere NL, Bridges JFP. Eliciting quality adjusted life years using the time trade off method for Prader-Willi syndrome. Patient. 2020;13(1):140.","journal-title":"Patient"},{"issue":"7","key":"3787_CR71","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1016\/j.clinthera.2021.05.013","volume":"43","author":"TA Lavelle","year":"2021","unstructured":"Lavelle TA, Crossnohere NL, Bridges JFP. Quantifying the burden of hyperphagia in Prader-Willi syndrome using quality-adjusted life-years. Clin Ther. 2021;43(7):1164-78.e4.","journal-title":"Clin Ther"},{"issue":"9","key":"3787_CR72","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1007\/s00787-014-0662-4","volume":"24","author":"ST Lo","year":"2015","unstructured":"Lo ST, Siemensma EP, Festen DA, Collin PJ, Hokken-Koelega AC. Behavior in children with Prader-Willi syndrome before and during growth hormone treatment: a randomized controlled trial and 8-year longitudinal study. Eur Child Adolesc Psychiatry. 2015;24(9):1091\u2013101.","journal-title":"Eur Child Adolesc Psychiatry"},{"issue":"Supplement 1","key":"3787_CR73","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s10198-016-0788-z","volume":"17","author":"J Lopez-Bastida","year":"2016","unstructured":"Lopez-Bastida J, Linertova R, Oliva-Moreno J, Posada-de-la-Paz M, Serrano-Aguilar P, Kanavos P, Taruscio D, Schieppati A, Iskrov G, Baji P, Delgado C, von der Schulenburg JMG, Persson U, Chevreul K, Fattore G. Social\/economic costs and health-related quality of life in patients with Prader-Willi syndrome in Europe. Eur J Health Econ. 2016;17(Supplement 1):99\u2013108.","journal-title":"Eur J Health Econ"},{"issue":"2","key":"3787_CR74","first-page":"22","volume":"34","author":"MC Maccarone","year":"2024","unstructured":"Maccarone MC, Avenia M, Masiero S. Postural-motor development, spinal range of movement and caregiver burden in Prader-Willi syndrome-associated scoliosis: an observational study. Eur J. 2024;34(2):22.","journal-title":"Eur J"},{"issue":"9","key":"3787_CR75","doi-asserted-by":"publisher","first-page":"3877","DOI":"10.1007\/s10803-021-05265-5","volume":"52","author":"J Mackay","year":"2022","unstructured":"Mackay J, Nixon GM, Lafferty AR, Ambler G, Kapur N, Bergman PB, Schofield C, Seton C, Tai A, Tham E, Vora K, Crock P, Verge C, Musthaffa Y, Blecher G, Caudri D, Leonard H, Jacoby P, Wilson A, Choong CS, Downs J. Associations between hyperphagia, symptoms of sleep breathing disorder, behaviour difficulties and caregiver well-being in Prader-Willi syndrome: a preliminary study. J Autism Dev Disord. 2022;52(9):3877\u201389.","journal-title":"J Autism Dev Disord"},{"issue":"5","key":"3787_CR76","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1007\/s12519-019-00311-w","volume":"15","author":"SJ Mao","year":"2019","unstructured":"Mao SJ, Shen J, Xu F, Zou CC. Quality of life in caregivers of young children with Prader-Willi syndrome. World J Pediatr. 2019;15(5):506\u201310.","journal-title":"World J Pediatr"},{"issue":"11","key":"3787_CR77","first-page":"504","volume":"13","author":"B-YH Mastey","year":"2024","unstructured":"Mastey B-YH, Gross-Tsur V, Hirsch HJ, Genstil L, Derei D, Forer D, Benarroch F. Quality of life for adults with Prader-Willi syndrome in residential group homes. Journal. 2024;13(11):504.","journal-title":"Journal"},{"issue":"1","key":"3787_CR78","first-page":"20573","volume":"13","author":"L Matesevac","year":"2023","unstructured":"Matesevac L, Vrana-Diaz CJ, Bohonowych JE, Schwartz L, Strong TV. Analysis of hyperphagia questionnaire for clinical trials (HQ-CT) scores in typically developing individuals and those with Prader-Willi syndrome. Sci. 2023;13(1):20573.","journal-title":"Sci"},{"issue":"12","key":"3787_CR79","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1111\/dom.13021","volume":"19","author":"SE McCandless","year":"2017","unstructured":"McCandless SE, Yanovski JA, Miller J, Fu C, Bird LM, Salehi P, et al. Effects of MetAP2 inhibition on hyperphagia and body weight in Prader-Willi syndrome: a randomized, double-blind, placebo-controlled trial. Diabetes Obes Metab. 2017;19(12):1751\u201361.","journal-title":"Diabetes Obes Metab"},{"key":"3787_CR80","unstructured":"McNulty BS, P. Kim, S. Kim, L. Howard, W. J. Aberrant Behavior Checklist Scores in Youth with Prader-Willi Syndrome. Pediatric Academic Societies Meeting 2023. 2023."},{"issue":"Supplement 2","key":"3787_CR81","first-page":"A227","volume":"104","author":"C Meade","year":"2019","unstructured":"Meade C, Martin R, Crowe C, Lyons J, McCrann A, Roche E. The impact of caring for a child with Prader Willi syndrome. Arch Dis Child. 2019;104(Supplement 2):A227.","journal-title":"Arch Dis Child"},{"issue":"Supplement 3","key":"3787_CR82","first-page":"A88","volume":"104","author":"C Meade","year":"2019","unstructured":"Meade C, Martin R, Lyons J, McCrann A, Roche E. Quality of life and the impact of caring for a child with Prader Willi syndrome. Arch Dis Child. 2019;104(Supplement 3):A88\u20139.","journal-title":"Arch Dis Child"},{"issue":"6","key":"3787_CR83","doi-asserted-by":"publisher","first-page":"e2373","DOI":"10.1210\/clinem\/dgac105","volume":"107","author":"JL Miller","year":"2022","unstructured":"Miller JL, Lacroix A, Bird LM, Shoemaker AH, Haqq A, Deal CL, Clark KA, Ames MH, Suico JG, de la Pe\u00f1a A, et al. The efficacy, safety, and pharmacology of a Ghrelin O-acyltransferase inhibitor for the treatment of Prader-Willi syndrome. J Clin Endocrinol Metab. 2022;107(6):e2373\u201380.","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"3787_CR84","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1210\/clinem\/dgad014","volume":"108","author":"JL Miller","year":"2023","unstructured":"Miller JL, Gevers E, Bridges N, Yanovski JA, Salehi P, Obrynba KS, Felner EI, Bird LM, Shoemaker AH, Angulo M, Butler MG, Stevenson D, Abuzzahab J, Barrett T, Lah M, Littlejohn E, Mathew V, Cowen NM, Bhatnagar A. Diazoxide choline extended-release tablet in people with Prader-Willi syndrome: a double-blind, Placebo-Controlled trial. J Clin Endocrinol Metab. 2023;108(7):1676\u201385.","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"3787_CR85","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1002\/oby.23928","volume":"32","author":"JL Miller","year":"2024","unstructured":"Miller JL, Gevers E, Bridges N, Yanovski JA, Salehi P, Obrynba KS, Felner EI, Bird LM, Shoemaker AH, Angulo M, Butler MG, Stevenson D, Goldstone AP, Wilding J, Lah M, Shaikh MG, Littlejohn E, Abuzzahab MJ, Fleischman A, Hirano P, Yen K, Cowen NM, Bhatnagar A. Diazoxide choline extended-release tablet in people with Prader-Willi syndrome: results from long-term open-label study. Obesity. 2024;32(2):252\u201361.","journal-title":"Obesity"},{"issue":"11","key":"3787_CR86","doi-asserted-by":"publisher","first-page":"23","DOI":"10.3390\/genes11111250","volume":"11","author":"AS Montes","year":"2020","unstructured":"Montes AS, Osann KE, Gold JA, Tamura RN, Driscoll DJ, Butler MG, Kimonis VE. Genetic subtype-phenotype analysis of growth hormone treatment on psychiatric behavior in Prader-Willi syndrome. Genes (Basel). 2020;11(11):23.","journal-title":"Genes (Basel)"},{"key":"3787_CR87","unstructured":"ClinicalTrials.gov. Cannabidiol Oral Solution for the Treatment of Patients With Prader-Willi Syndrome NCT02844933 [Trial registry record]. 2016 [Available from: https:\/\/www.cochranelibrary.com\/central\/doi\/10.1002\/central\/CN-01507046\/full]. Last accessed Last accessed: 31 January 2025."},{"key":"3787_CR88","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.ridd.2015.12.017","volume":"51\u201352","author":"LP O'Neill","year":"2016","unstructured":"O\u2019Neill LP, Murray LE. Anxiety and depression symptomatology in adult siblings of individuals with different developmental disability diagnoses. Res Dev Disabil. 2016;51\u201352:116\u201325.","journal-title":"Res Dev Disabil"},{"issue":"Supplement 1","key":"3787_CR89","doi-asserted-by":"publisher","first-page":"S208","DOI":"10.1016\/j.jval.2021.04.1045","volume":"24","author":"V Patel","year":"2021","unstructured":"Patel V, Davis K, Merikle E, McClure E, Patroneva A. PRO60 the epworth sleepiness scale for children and adolescents is a fit-for-purpose measure of daytime sleepiness in Prader-Willi syndrome: a qualitative interview study. Value in Health. 2021;24(Supplement 1):S208.","journal-title":"Value in Health"},{"issue":"2","key":"3787_CR90","doi-asserted-by":"publisher","first-page":"485","DOI":"10.5664\/jcsm.9632","volume":"18","author":"VP Patel","year":"2022","unstructured":"Patel VP, Patroneva A, Glaze DG, Davis K, Merikle E, Revana A. Establishing the content validity of the epworth sleepiness scale for children and adolescents in Prader-Willi syndrome. J Clin Sleep Med. 2022;18(2):485\u201396.","journal-title":"J Clin Sleep Med"},{"issue":"5","key":"3787_CR91","first-page":"347","volume":"70","author":"B Pedemonti","year":"2023","unstructured":"Pedemonti B, Ceccomancini R, D\u2019Acunti A, Stegmann J. Effectiveness of a transdisciplinary approach on hyperphagia management among patients with Prader Willi syndrome. Endocrinol Diabetes Nutr (Engl Ed). 2023;70(5):347\u201351.","journal-title":"Endocrinol Diabetes Nutr (Engl Ed)"},{"issue":"1","key":"3787_CR92","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1186\/s12888-021-03436-3","volume":"21","author":"A Peleggi","year":"2021","unstructured":"Peleggi A, Bohonowych J, Strong TV, Schwartz L, Kim SJ. Suicidality in individuals with Prader-Willi syndrome: a review of registry survey data. BMC Psychiatry. 2021;21(1):438.","journal-title":"BMC Psychiatry"},{"issue":"8","key":"3787_CR93","doi-asserted-by":"publisher","first-page":"e036502","DOI":"10.1136\/bmjopen-2019-036502","volume":"10","author":"L Ragusa","year":"2020","unstructured":"Ragusa L, Crino A, Grugni G, Reale L, Fiorencis A, Licenziati MR, Faienza MF, Wasniewska M, Delvecchio M, Franzese A, Rutigliano I, Fusilli P, Corica D, Campana G, Greco D, Chiarito M, Sacco M, Toscano S, Marini MG. Caring and living with Prader-Willi syndrome in Italy: integrating children, adults and parents\u2019 experiences through a multicentre narrative medicine research. BMJ Open. 2020;10(8):e036502.","journal-title":"BMJ Open"},{"issue":"5","key":"3787_CR94","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1007\/s10897-015-9820-1","volume":"24","author":"C Reilly","year":"2015","unstructured":"Reilly C, Murtagh L, Senior J. The impact on the family of four neurogenetic syndromes: a comparative study of parental views. J Genet Couns. 2015;24(5):851\u201361.","journal-title":"J Genet Couns"},{"issue":"2","key":"3787_CR95","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1002\/ajmg.c.31442","volume":"169","author":"LJ Rice","year":"2015","unstructured":"Rice LJ, Gray KM, Howlin P, Taffe J, Tonge BJ, Einfeld SL. The developmental trajectory of disruptive behavior in Down syndrome, fragile X syndrome, Prader-Willi syndrome and Williams syndrome. Am J Med Genet C Semin Med Genet. 2015;169(2):182\u20137.","journal-title":"Am J Med Genet C Semin Med Genet"},{"issue":"1","key":"3787_CR96","doi-asserted-by":"publisher","first-page":"06","DOI":"10.3390\/diseases4010009","volume":"4","author":"LJ Rice","year":"2016","unstructured":"Rice LJ, Gray KM, Howlin P, Taffe J, Tonge BJ, Einfeld SL. The developmental trajectory of self-injurious behaviours in individuals with Prader Willi syndrome, autism spectrum disorder and intellectual disability. Diseases. 2016;4(1):06.","journal-title":"Diseases"},{"issue":"7","key":"3787_CR97","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1210\/clinem\/dgad015","volume":"108","author":"E Roof","year":"2023","unstructured":"Roof E, Deal CL, McCandless SE, Cowan RL, Miller JL, Hamilton JK, Roeder ER, McCormack SE, Roshan LT, et al. Intranasal carbetocin reduces hyperphagia, anxiousness, and distress in Prader-Willi syndrome: CARE-PWS phase 3 trial. J Clin Endocrinol Metab. 2023;108(7):1696\u2013708.","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"3787_CR98","first-page":"670","volume":"62","author":"R Royston","year":"2018","unstructured":"Royston R, Waite J, Howlin P, Dosse A, Armitage P, Moss J, Oliver C. Cross-syndrome comparison of psychopathological risk factors in williams syndrome, fragile x syndrome and prader-willi syndrome. J Intellect Disabil Res. 2018;62(8):670.","journal-title":"J Intellect Disabil Res"},{"issue":"3","key":"3787_CR99","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1007\/s10803-019-04317-1","volume":"50","author":"R Royston","year":"2020","unstructured":"Royston R, Oliver C, Howlin P, Dosse A, Armitage P, Moss J, Waite J. The profiles and correlates of psychopathology in adolescents and adults with Williams, Fragile X and Prader-Willi syndromes. J Autism Dev Disord. 2020;50(3):893\u2013903.","journal-title":"J Autism Dev Disord"},{"issue":"23","key":"3787_CR100","doi-asserted-by":"publisher","first-page":"589","DOI":"10.3390\/ijerph192316330","volume":"19","author":"A Rozensztrauch","year":"2022","unstructured":"Rozensztrauch A, Smigiel R. Quality of life in children with Prader-Willi syndrome and the impact of the disease on the functioning of families. Int J Environ Res Public Health. 2022;19(23):589.","journal-title":"Int J Environ Res Public Health."},{"issue":"3","key":"3787_CR101","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.jadohealth.2018.11.014","volume":"65","author":"DA Rubin","year":"2019","unstructured":"Rubin DA, Wilson KS, Castner DM, Dumont-Driscoll MC. Changes in health-related outcomes in youth with obesity in response to a home-based parent-led physical activity program. J Adolesc Health. 2019;65(3):323\u201330.","journal-title":"J Adolesc Health"},{"issue":"4","key":"3787_CR102","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1123\/pes.2020-0160","volume":"33","author":"DA Rubin","year":"2021","unstructured":"Rubin DA, Wilson KS, Tucker JM, Castner DM, Dumont-Driscoll MC, Rose DJ. Improved motor proficiency and quality of life in youth with Prader-Willi syndrome and obesity 6 months after completing a parent-led, game-based intervention. Pediatr Exerc Sci. 2021;33(4):177\u201385.","journal-title":"Pediatr Exerc Sci"},{"key":"3787_CR103","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1016\/j.ridd.2020.103839","volume":"110","author":"C Schofield","year":"2021","unstructured":"Schofield C, Martin KS, Choong C, Gibson D, Skoss R, Downs J. Using a trauma informed practice framework to enhance understanding of and identify support strategies for behavioural difficulties in young people with Prader-Willi syndrome. Res Dev Disabil. 2021;110:528.","journal-title":"Res Dev Disabil."},{"issue":"6","key":"3787_CR104","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1007\/s10803-016-2741-5","volume":"46","author":"CM Shivers","year":"2016","unstructured":"Shivers CM, Leonczyk CL, Dykens EM. Life satisfaction among mothers of individuals with Prader-Willi syndrome. J Autism Dev Disord. 2016;46(6):2126\u201337.","journal-title":"J Autism Dev Disord"},{"key":"3787_CR105","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.eurpsy.2017.03.007","volume":"44","author":"L Shriki-Tal","year":"2017","unstructured":"Shriki-Tal L, Avrahamy H, Pollak Y, Gross-Tsur V, Genstil L, Hirsch HJ, Benarroch F. Psychiatric disorders in a cohort of individuals with Prader-Willi syndrome. Eur Psychiatry. 2017;44:47\u201352.","journal-title":"Eur Psychiatry"},{"issue":"1","key":"3787_CR106","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s11689-024-09536-x","volume":"16","author":"TV Strong","year":"2024","unstructured":"Strong TV, Miller JL, McCandless SE, Gevers E, Yanovski JA, Matesevac L, Bohonowych J, Ballal S, Yen K, Hirano P, Cowen NM, Bhatnagar A. Behavioral changes in patients with Prader-Willi syndrome receiving diazoxide choline extended-release tablets compared to the PATH for PWS natural history study. J Neurodev Disord. 2024;16(1):22.","journal-title":"J Neurodev Disord"},{"issue":"8","key":"3787_CR107","doi-asserted-by":"publisher","first-page":"763","DOI":"10.3109\/09638288.2016.1161838","volume":"39","author":"A Thomson","year":"2017","unstructured":"Thomson A, Glasson E, Roberts P, Bittles A. \u201cOver time it just becomes easier\u2026\u201d: parents of people with Angelman syndrome and Prader-Willi syndrome speak about their carer role. Disabil Rehabil. 2017;39(8):763\u201370.","journal-title":"Disabil Rehabil."},{"issue":"1","key":"3787_CR108","first-page":"132","volume":"189","author":"DJ Trueba-Timmermans","year":"2023","unstructured":"Trueba-Timmermans DJ, Grootjen LN, Juriaans AF, Mahabier EF, Kerkhof GF, Rings EHHM, Hokken-Koelega ACS. Cognitive function during 3 years of growth hormone in previously growth hormone-treated young adults with Prader-Willi syndrome. Eur. 2023;189(1):132\u20139.","journal-title":"Eur"},{"issue":"5","key":"3787_CR109","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1002\/ajmg.a.36971","volume":"167A","author":"T Tvrdik","year":"2015","unstructured":"Tvrdik T, Mason D, Dent KM, Thornton L, Hornton SN, Viskochil DH, Stevenson DA. Stress and coping in parents of children with Prader-Willi syndrome: assessment of the impact of a structured plan of care. Am J Med Genet A. 2015;167A(5):974\u201382.","journal-title":"Am J Med Genet A"},{"issue":"1","key":"3787_CR110","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.pedn.2015.11.001","volume":"31","author":"SA Vitale","year":"2016","unstructured":"Vitale SA. Parent recommendations for family functioning with Prader-Willi syndrome: a rare genetic cause of childhood obesity. J Pediatr Nurs. 2016;31(1):47\u201354.","journal-title":"J Pediatr Nurs"},{"issue":"7","key":"3787_CR111","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1111\/jir.12831","volume":"65","author":"J Wieting","year":"2021","unstructured":"Wieting J, Eberlein C, Bleich S, Frieling H, Deest M. Behavioural change in Prader-Willi syndrome during COVID-19 pandemic. J Intellect Disabil Res. 2021;65(7):609\u201316.","journal-title":"J Intellect Disabil Res"},{"key":"3787_CR112","first-page":"852","volume":"15","author":"J Wieting","year":"2021","unstructured":"Wieting J, Jahn K, Buchholz V, Lichtinghagen R, Bleich S, Eberlein CK, Deest M, Frieling H. Alteration of serum leptin and LEP\/LEPR promoter methylation in Prader-Willi syndrome. medRxiv. 2021;15:852.","journal-title":"medRxiv."},{"key":"3787_CR113","doi-asserted-by":"publisher","first-page":"105857","DOI":"10.1016\/j.psyneuen.2022.105857","volume":"143","author":"J Wieting","year":"2022","unstructured":"Wieting J, Jahn K, Buchholz V, Lichtinghagen R, Deest-Gaubatz S, Bleich S, Eberlein CK, Deest M, Frieling H. Alteration of serum leptin and LEP\/LEPR promoter methylation in Prader-Willi syndrome. Psychoneuroendocrinology. 2022;143:105857.","journal-title":"Psychoneuroendocrinology"},{"key":"3787_CR114","doi-asserted-by":"publisher","first-page":"114494","DOI":"10.1016\/j.bbr.2023.114494","volume":"450","author":"J Wieting","year":"2023","unstructured":"Wieting J, Jahn K, Eberlein CK, Bleich S, Frieling H, Deest M. Hypomethylation of the dopamine transporter (DAT) gene promoter is associated with hyperphagia-related behavior in Prader-Willi syndrome: a case-control study. Behav Brain Res. 2023;450:114494.","journal-title":"Behav Brain Res"},{"key":"3787_CR115","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.ridd.2016.06.016","volume":"57","author":"KS Wilson","year":"2016","unstructured":"Wilson KS, Wiersma LD, Rubin DA. Quality of life in children with Prader Willi Syndrome: parent and child reports. Res Dev Disabil. 2016;57:149\u201357.","journal-title":"Res Dev Disabil"},{"issue":"1","key":"3787_CR116","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1002\/ajmg.a.61915","volume":"185","author":"SB Wong","year":"2021","unstructured":"Wong SB, Wang TS, Tsai WH, Tzeng IS, Tsai LP. Parenting stress in families of children with Prader-Willi syndrome. Am J Med Genet A. 2021;185(1):83\u20139.","journal-title":"Am J Med Genet A"},{"issue":"1","key":"3787_CR117","first-page":"4978","volume":"12","author":"K Yamada","year":"2022","unstructured":"Yamada K, Watanabe M, Suzuki K. Differential volume reductions in the subcortical, limbic, and brainstem structures associated with behavior in Prader-Willi syndrome. Sciences. 2022;12(1):4978.","journal-title":"Sciences"},{"key":"3787_CR118","unstructured":"ClinicalTrials.gov. Oxytocin vs. Placebo for the Treatment Hyperphagia in Children and Adolescents With Prader-Willi Syndrome NCT02629991 [Trial registry record]. 2015 [Available from: https:\/\/www.cochranelibrary.com\/central\/doi\/10.1002\/central\/CN-01554390\/full]. Last accessed Last accessed: 31 January 2025."},{"issue":"1","key":"3787_CR119","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1352\/0895-8017(2007)112[31:SFOTDB]2.0.CO;2","volume":"112","author":"JR Taffe","year":"2007","unstructured":"Taffe JR, Gray KM, Einfeld SL, Dekker MC, Koot HM, Emerson E, et al. Short form of the developmental behaviour checklist. Am J Ment Retard. 2007;112(1):31\u20139.","journal-title":"Am J Ment Retard"},{"key":"3787_CR120","unstructured":"Varni JW. The PedsQL Measurement Model for the Pediatric Quality of Life Inventory: PedsMetrics; [Available from: https:\/\/www.pedsql.org\/about_pedsql.html]. Last accessed Last accessed: 10 January 2025."},{"issue":"5","key":"3787_CR121","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1111\/j.1524-4733.2008.00487.x","volume":"12","author":"IC Huang","year":"2009","unstructured":"Huang IC, Thompson LA, Chi YY, Knapp CA, Revicki DA, Seid M, et al. The linkage between pediatric quality of life and health conditions: establishing clinically meaningful cutoff scores for the PedsQL. Value Health. 2009;12(5):773\u201381.","journal-title":"Value Health"},{"key":"3787_CR122","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-030-47622-9","volume-title":"Methods for Analysing and Reporting EQ-5D Data","author":"N Devlin","year":"2020","unstructured":"Devlin N, Parkin D, Janssen B. Methods for Analysing and Reporting EQ-5D Data. 1st ed. Springer; 2020.","edition":"1"},{"key":"3787_CR123","unstructured":"RAND. 36-Item Short Form Survey (SF-36): RAND; [Available from: https:\/\/www.rand.org\/health-care\/surveys_tools\/mos\/36-item-short-form.html]. Last accessed Last accessed: 10 January 2025."},{"issue":"Supplement 1","key":"3787_CR124","first-page":"172","volume":"91","author":"S Mao","year":"2019","unstructured":"Mao S, Shen J, Yang L, Yang R, Zou C, Zhao Z. Quality of life in caregivers of young children with Prader-Willi syndrome. Hormone Res Paediatr. 2019;91(Supplement 1):172\u20133.","journal-title":"Hormone Res Paediatr"},{"issue":"5","key":"3787_CR125","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1002\/ajmg.a.33951","volume":"155A","author":"JL Miller","year":"2011","unstructured":"Miller JL, Lynn CH, Driscoll DC, Goldstone AP, Gold JA, Kimonis V, et al. Nutritional phases in Prader-Willi syndrome. Am J Med Genet A. 2011;155A(5):1040\u20139.","journal-title":"Am J Med Genet A"},{"issue":"4","key":"3787_CR126","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.1007\/s10803-021-05193-4","volume":"53","author":"EK Baker","year":"2023","unstructured":"Baker EK, Arora S, Amor DJ, Date P, Cross M, O\u2019Brien J, Simons C, Rogers C, Goodall S, Slee J, Cahir C, Godler DE. The cost of raising individuals with Fragile X or chromosome 15 imprinting disorders in Australia. J Autism Dev Disord. 2023;53(4):1682\u201392.","journal-title":"J Autism Dev Disord"},{"issue":"1","key":"3787_CR127","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/s13023-017-0673-6","volume":"12","author":"C Bar","year":"2017","unstructured":"Bar C, Diene G, Molinas C, Bieth E, Casper C, Tauber M. Early diagnosis and care is achieved but should be improved in infants with Prader-Willi syndrome. Orphanet J Rare Dis. 2017;12(1):118.","journal-title":"Orphanet J Rare Dis"},{"key":"3787_CR128","doi-asserted-by":"publisher","first-page":"5332","DOI":"10.1016\/j.jval.2020.04.1251","volume":"23","author":"MG Butler","year":"2020","unstructured":"Butler MG, Manzardo A, Strong TV, Li JW, Yin D, Meng Q, Silber A, Francis K, Hadker N, Czado S, Yeh M, Miller JL. Pro22 cost of care analysis for U.S. patients with Prader-Willi syndrome (Pws). Value in Health. 2020;23:5332.","journal-title":"Value in Health."},{"issue":"22","key":"3787_CR129","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1097\/BRS.0000000000003134","volume":"44","author":"AS Chung","year":"2019","unstructured":"Chung AS, Renfree S, Lockwood DB, Karlen J, Belthur M. Syndromic scoliosis: national trends in surgical management and inpatient hospital outcomes: a 12-year analysis. Spine. 2019;44(22):1564\u201370.","journal-title":"Spine"},{"issue":"22","key":"3787_CR130","first-page":"15","volume":"10","author":"A Clerc","year":"2021","unstructured":"Clerc A, Coupaye M, Mosbah H, Pinto G, Laurier V, Mourre F, Merrien C, Diene G, Poitou C, Tauber M. Diabetes mellitus in prader-willi syndrome: natural history during the transition from childhood to adulthood in a cohort of 39 patients. Journal. 2021;10(22):15.","journal-title":"Journal"},{"issue":"3","key":"3787_CR131","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1002\/phar.1558","volume":"35","author":"JP Elliott","year":"2015","unstructured":"Elliott JP, Cherpes G, Kamal K, Chopra I, Harrison C, Riedy M, Herk B, McCrossin M, Kalarchian M. Relationship between antipsychotics and weight in patients with Prader-Willi syndrome. Pharmacotherapy. 2015;35(3):260\u20138.","journal-title":"Pharmacotherapy"},{"issue":"4","key":"3787_CR132","first-page":"299","volume":"47","author":"Y Gul","year":"2022","unstructured":"Gul Y, Kapakli H, Aytekin SE, Guner SN, Keles S, Zamani AG, Yildirim MS, Reisli I. Evaluation of immunological abnormalities in patients with rare syndromes. Central Eur J Urol. 2022;47(4):299\u2013307.","journal-title":"Central Eur J Urol"},{"issue":"1","key":"3787_CR133","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s13023-024-03035-x","volume":"19","author":"BM Hughes","year":"2024","unstructured":"Hughes BM, Holland A, Hodebeck-Stuntebeck N, Garrick L, Goldstone AP, Lister M, Moore C, Hughes M. Body weight, behaviours of concern, and social contact in adults and adolescents with Prader-Willi syndrome in full-time care services: findings from pooled international archival data. Orphanet J Rare Dis. 2024;19(1):48.","journal-title":"Orphanet J Rare Dis"},{"issue":"5","key":"3787_CR134","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1111\/jir.12140","volume":"59","author":"V Laurier","year":"2015","unstructured":"Laurier V, Lapeyrade A, Copet P, Demeer G, Silvie M, Bieth E, Coupaye M, Poitou C, Lorenzini F, Labrousse F, Molinas C, Tauber M, Thuilleaux D, Jauregi J. Medical, psychological and social features in a large cohort of adults with Prader-Willi syndrome: experience from a dedicated centre in France. J Intellect Disabil Res. 2015;59(5):411\u201321.","journal-title":"J Intellect Disabil Res"},{"issue":"6","key":"3787_CR135","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1007\/s43390-021-00359-7","volume":"9","author":"KS McQuivey","year":"2021","unstructured":"McQuivey KS, Sheridan JR, Chung A, Mayfield C, Gulbrandsen M, Brinkman JC, Belthur MV. Hospital outcomes of scoliosis surgery in children with Prader-Willi Syndrome: comparison with adolescent idiopathic scoliosis. Spine Deformity. 2021;9(6):1641\u20137.","journal-title":"Spine Deformity"},{"issue":"6","key":"3787_CR136","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1016\/j.jos.2021.08.005","volume":"27","author":"KS McQuivey","year":"2022","unstructured":"McQuivey KS, Chung AS, Jones MR, Makovicka JL, Christopher ZK, Brinkman JC, Belthur M. Hospital outcomes in pediatric patients with Prader-Willi syndrome (PWS) undergoing orthopedic surgery: a 12-year analysis of national trends in surgical management and inpatient hospital outcomes. J Orthop Sci. 2022;27(6):1304\u20138.","journal-title":"J Orthop Sci"},{"issue":"Supplement 3","key":"3787_CR137","first-page":"A117","volume":"104","author":"C Meade","year":"2019","unstructured":"Meade C, Martin R, McCrann A, Lyons J, Roche E. Growth and nutritional status in children with Prader Willi syndrome. Arch Dis Child. 2019;104(Supplement 3):A117\u20138.","journal-title":"Arch Dis Child"},{"issue":"17","key":"3787_CR138","first-page":"25","volume":"10","author":"K Pellikaan","year":"2021","unstructured":"Pellikaan K, Snijders F, Rosenberg AGW, Davidse K, van Berg SAA, Visser WE, et al. Thyroid function in adults with prader-willi syndrome; a cohort study and literature review. Journal. 2021;10(17):25.","journal-title":"Journal"},{"issue":"2","key":"3787_CR139","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1002\/ajmg.a.61968","volume":"185","author":"G Pemmasani","year":"2021","unstructured":"Pemmasani G, Yandrapalli S. Age-stratified prevalence of relevant comorbidities and etiologies for hospitalizations in Prader-Willi syndrome patients. Am J Med Genet A. 2021;185(2):600\u20131.","journal-title":"Am J Med Genet A"},{"issue":"7","key":"3787_CR140","doi-asserted-by":"publisher","first-page":"A575","DOI":"10.1016\/j.jval.2015.09.1907","volume":"18","author":"R Potluri","year":"2015","unstructured":"Potluri R, Ranjan S, Khurana R, Lele AM, Prabhakar V, Bhandari H. Evaluation of average cost-effectiveness ratios of standards of care across different indications. Value Health. 2015;18(7):A575.","journal-title":"Value Health"},{"issue":"4","key":"3787_CR141","first-page":"273","volume":"12","author":"C Prapasrat","year":"2021","unstructured":"Prapasrat C, Onsod P, Korkiatsakul V, Rerkamnuaychoke B, Wattanasirichaigoon D, Chareonsirisuthigul T. The utilization of MS-MLPA as the first-line test for the diagnosis of prader-willi syndrome in thai patients. J Pediatr Genet. 2021;12(4):273\u20139.","journal-title":"J Pediatr Genet"},{"issue":"1","key":"3787_CR142","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.hlpt.2021.02.002","volume":"10","author":"AR Sequeira","year":"2021","unstructured":"Sequeira AR, Mentzakis E, Archangelidi O, Paolucci F. The economic and health impact of rare diseases: a meta-analysis. Health Policy Technol. 2021;10(1):32\u201344.","journal-title":"Health Policy Technol"},{"issue":"6","key":"3787_CR143","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1136\/archdischild-2018-316262","volume":"104","author":"S Shepherd","year":"2019","unstructured":"Shepherd S, Saraff V, Shaw N, Banerjee I, Patel L. Growth hormone prescribing patterns in the UK, 2013\u20132016. Arch Dis Child. 2019;104(6):583\u20137.","journal-title":"Arch Dis Child"},{"key":"3787_CR144","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.jpeds.2016.05.018","volume":"175","author":"AJ Shoffstall","year":"2016","unstructured":"Shoffstall AJ, Gaebler JA, Kreher NC, Niecko T, Douglas D, Strong TV, Miller JL, Stafford DE, Butler MG. The high direct medical costs of prader-willi syndrome. J Pediatr. 2016;175:137\u201343.","journal-title":"J Pediatr"},{"issue":"5","key":"3787_CR145","doi-asserted-by":"publisher","first-page":"E362","DOI":"10.1097\/BPO.0000000000001490","volume":"40","author":"HJP Van Bosse","year":"2020","unstructured":"Van Bosse HJP, Gantz MG, Ong KL, Cox JB. Comparison of Hip and Knee arthroplasty rates of individuals with and without prader-willi syndrome. J Pediatric Orthop. 2020;40(5):E362\u20136.","journal-title":"J Pediatric Orthop"},{"issue":"Supplement 1","key":"3787_CR146","first-page":"300","volume":"91","author":"L Yang","year":"2019","unstructured":"Yang L, Zou C. Perinatal features of prader-willi syndrome: a Chinese cohort. Hormone Res Paediatr. 2019;91(Supplement 1):300.","journal-title":"Hormone Res Paediatr"},{"issue":"1","key":"3787_CR147","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s13023-020-1306-z","volume":"15","author":"L Yang","year":"2020","unstructured":"Yang L, Zhou Q, Ma B, Mao S, Dai Y, Zhu M, Zou C. Perinatal features of Prader-Willi syndrome: a Chinese cohort of 134 patients. Orphanet J Rare Dis. 2020;15(1):24.","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"3787_CR148","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s13679-024-00601-z","volume":"14","author":"SB Heymsfield","year":"2025","unstructured":"Heymsfield SB, Clement K, Dubern B, Goldstone AP, Haqq AM, Kuhnen P, et al. Defining hyperphagia for improved diagnosis and management of MC4R pathway-associated disease: a roundtable summary. Curr Obes Rep. 2025;14(1):13.","journal-title":"Curr Obes Rep"},{"issue":"1","key":"3787_CR149","doi-asserted-by":"publisher","first-page":"104379","DOI":"10.1016\/j.ejmg.2021.104379","volume":"65","author":"SA Bellis","year":"2022","unstructured":"Bellis SA, Kuhn I, Adams S, Mullarkey L, Holland A. The consequences of hyperphagia in people with Prader-Willi Syndrome: a systematic review of studies of morbidity and mortality. Eur J Med Genet. 2022;65(1):104379.","journal-title":"Eur J Med Genet"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-03787-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-025-03787-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-03787-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T23:32:26Z","timestamp":1757287946000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-025-03787-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,24]]},"references-count":149,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3787"],"URL":"https:\/\/doi.org\/10.1186\/s13023-025-03787-0","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,24]]},"assertion":[{"value":"14 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Dairine DEMPSEY is an employee of Soleno Therapeutics Europe Ltd. Michael HUANG, Neil COWEN, Mitch NAGAO, Raj GANDHI and Anish BHATNAGAR are employees of Soleno Therapeutics Inc, USA. Maria HALL is a contractor for Soleno Therapeutics Europe Ltd. Kintiga was commissioned to undertake the systematic literature review. Ben LANNING and Ben BARRON-MILLAR are employees of Kintiga.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"374"}}